Product Information
DEXLANSOPRAZOLE DR 30 MG CAP is a generic product labeled by Endo USA Inc., priced at $4.1649 per EA under NDC 49884014711. Its NADAC has been published 155 times since Jul 12, 2023.
Strength
30 mg/1
Manufacturer
Endo USA Inc.NDC
49884014711
Classification
Generic
Dosage Form
CAPSULE, DELAYED RELEASE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
DEXLANSOPRAZOLEApproval Type
Generic (ANDA)
FDA Application
ANDA202294On Market Since
6/10/2023
Pharmacological Classes
Price Statistics
The NADAC for DEXLANSOPRAZOLE DR 30 MG CAP has been published 155 times since Jul 12, 2023, and over the history we have for it it has declined 43.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $4.1649 per EA |
|---|---|
| All-time high | $7.6443 (Feb 14, 2024) |
| All-time low | $3.8700 (Jul 17, 2024) |
| 52-week high | $4.8639 |
| 52-week low | $4.1649 |
| Median price | $4.8639 |
| Average price | $5.3580 |
| Largest weekly change | +32.8% (Aug 21, 2024) |
| Weeks tracked | 155 |
| Tracking since | Jul 12, 2023 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of DEXLANSOPRAZOLE DR 30 MG CAP?
The current National Average Drug Acquisition Cost (NADAC) for DEXLANSOPRAZOLE DR 30 MG CAP, manufactured by Endo USA Inc., is $4.1649 per EA (NDC 49884014711), effective Jun 24, 2026.
How has the price of DEXLANSOPRAZOLE DR 30 MG CAP changed over time?
Over the history we have for it, the NADAC for DEXLANSOPRAZOLE DR 30 MG CAP has declined 43.6%. It has been tracked across 155 weekly CMS publications since Jul 12, 2023.
What are the highest and lowest recorded NADAC prices for DEXLANSOPRAZOLE DR 30 MG CAP?
Since Jul 12, 2023, the NADAC for DEXLANSOPRAZOLE DR 30 MG CAP has ranged from a low of $3.8700 (Jul 17, 2024) to a high of $7.6443 (Feb 14, 2024), with a median of $4.8639 per EA.
Are there cheaper alternatives to DEXLANSOPRAZOLE DR 30 MG CAP?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as DEXLANSOPRAZOLE DR 30 MG CAP, but none are currently priced below it.
Who manufactures DEXLANSOPRAZOLE DR 30 MG CAP?
DEXLANSOPRAZOLE DR 30 MG CAP (NDC 49884014711) is labeled by Endo USA Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification